|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 401/04 | (2006.01) | ||
| C07D 403/10 | (2006.01) | ||
| C07D 213/82 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2861579 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13730652.8 |
| Europos patento paraiškos padavimo data | 2013-05-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-21 |
| (46) | Apibrėžties vertimo paskelbimo data | 2018-05-10 |
| (86) | Numeris | PCT/IB2013/053768 |
| Data | 2013-05-09 |
| (87) | Numeris | WO 2013/171639 |
| Data | 2013-11-21 |
| (30) | Numeris | Data | Šalis |
| 201261647174 P | 2012-05-15 | US | |
| 201361790967 P | 2013-03-15 | US |
| (72) |
DODD, Stephanie Kay, US
FURET, Pascal, CH
GROTZFELD, Robert Martin, CH
JONES, Darryl Brynley, CH
MANLEY, Paul, CH
MARZINZIK, Andreas, CH
PELLE, Xavier Francois Andre, CH
SALEM, Bahaa, CH
SCHOEPFER, Joseph, CH
JAHNKE, Wolfgang, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Benzamido dariniai, skirti ABL1, ABL2 ir BCR-ABL1 aktyvumo inhibavimui |
| BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-04-22 | 13 | 289.00 EUR |
| 2026-05-09 |